This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Johns Hopkins University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of James Meixiong in Chronic Itch Treatment
Introduction
James Meixiong is an accomplished inventor based in Baltimore, MD (US). He has made significant contributions to the field of medicine, particularly in the treatment of chronic itch conditions. His innovative approach focuses on the use of small molecule MrgprX4 antagonists to alleviate symptoms associated with various medical conditions.
Latest Patents
James Meixiong holds a patent for a method that treats chronic itch conditions by administering small molecule MrgprX4 antagonists. This invention relates to cells and methods for detecting compounds that affect G protein-coupled receptor-mediated conditions. Additionally, it addresses methods for treating adverse drug reactions, autoimmune disorders, and pruritus.
Career Highlights
James is affiliated with The Johns Hopkins University, where he continues to advance his research and innovations. His work has garnered attention for its potential to improve the quality of life for individuals suffering from chronic itch and related conditions.
Collaborations
James collaborates with notable colleagues, including Xinzhong Dong and Chirag Vasavda, who contribute to his research endeavors and help enhance the impact of his inventions.
Conclusion
James Meixiong's innovative work in treating chronic itch conditions showcases the importance of research and development in medicine. His contributions have the potential to significantly improve patient care and treatment outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile